The House of Representatives recently passed a Medicare bill
that reduces the copay for Medicare patients from 50% to 20%, the rate it is
for all other medical specialties.
That may not seem like a big deal—and if it doesn't, you probably
don't have Medicare.
An even more interesting provision of this bill is that it... Read more
Richard Friedman, MD, recently wrote an article in the New York Times about our troubled
relationship with antidepressants. He opens his article by asking how antidepressants might affect a patient's psychological development and core identity.
It's an interesting question, one which some have discussed
in the past, but which is... Read more
There is some new data concerning an old drug. Mecamylamine is an old medication originally used to treat hypertension. It had numerous side effects, such as hypotension and sedation, and thus was not often used. It had a bit of a resurgence later on as an anti-smoking drug (it is a nicotine antagonist) but the overall efficacy was poor,... Read more
USA TODAY is running an article concerning direct to consumer ads about medications. Patients see the ads, and then go to the doctor requesting that or a similar medication, and the doctor feels some pressure to prescribe something. The result is that even more money is spent on medications. There are a few points to be made. ... Read more
When does a doctor recommend ECT? Unfortunately, the answer depends much more on who the doctor is than what a clearly defined hierarchy of treatment modalities might suggest. Generally, ECT is considered to be efficacious, but with numerous limitations. It must be done in a hospital setting - an anesthesiologist is required, to... Read more